# GLP-1 Receptor Agonists, Answered: Top Questions

**By TelosRX Editorial Team** · 2026-11-13

**A GLP-1 receptor agonist is a medication that mimics GLP-1, a gut hormone that boosts insulin, slows digestion and quiets appetite. Semaglutide and tirzepatide are the best-known examples. [TelosRX](https://telosrx.com) answers the questions people actually search.**

Search for "GLP-1 receptor agonist" and you get two kinds of results. Dense medical reviews, or brand pages selling one product. Neither answers the plain questions.

So our clinical team pulled the most-searched questions and answered each one in plain English. Every answer below is drawn from FDA labeling or published research, not forum lore.

## What Is a GLP-1 Receptor Agonist?

GLP-1 stands for glucagon-like peptide-1. It's a hormone your gut releases after you eat. It tells your body food has arrived.

An "agonist" is a drug that switches a receptor on. So a GLP-1 receptor agonist (often shortened to GLP-1 RA) is a drug that switches on the same receptor your own GLP-1 uses.

The catch with natural GLP-1? It breaks down in about two minutes. Drug makers re-engineered the molecule so it lasts a day or even a full week. That's why most modern options are once-weekly shots.

## How Do GLP-1 Receptor Agonists Work in the Body?

They act in several places at once. According to the [NIH StatPearls review of GLP-1 agonists](https://www.ncbi.nlm.nih.gov/books/NBK551568/), the main effects include:

-   **Pancreas:** more insulin when blood sugar rises, and less glucagon (a hormone that raises blood sugar).
-   **Stomach:** slower emptying, so meals stay with you longer.
-   **Brain:** stronger fullness signals in appetite centers like the hypothalamus.
-   **Reward system:** many people report less "food noise," or constant thoughts about food.

The insulin effect is glucose-dependent. That means it mostly kicks in when blood sugar is high. It's one reason these drugs rarely cause low blood sugar on their own. For the full mechanism, see our explainer on [how GLP-1 works](https://www.telosrx.com/blogs/glp1/how-does-glp1-work-mechanism-weight-loss).

## Which GLP-1 Receptor Agonists Are FDA-Approved?

Several brands are FDA-approved, each for a specific use. Here's a quick map of the main ones.

| Generic name | Brand names | Form and schedule | Approved focus |
| --- | --- | --- | --- |
| Exenatide | Byetta | Injection, twice daily | Type 2 diabetes |
| Liraglutide | Victoza, Saxenda | Injection, daily | Type 2 diabetes (Victoza); weight management (Saxenda) |
| Dulaglutide | Trulicity | Injection, weekly | Type 2 diabetes |
| Semaglutide | Ozempic, Wegovy, Rybelsus | Weekly injection or daily tablet | Type 2 diabetes (Ozempic, Rybelsus); weight management (Wegovy) |
| Tirzepatide | Mounjaro, Zepbound | Injection, weekly | Type 2 diabetes (Mounjaro); weight management (Zepbound) |

Each brand has its own label, dose steps and approved population. Newer oral options keep arriving too. Our [Foundayo vs tirzepatide comparison](https://www.telosrx.com/blogs/glp1/foundayo-vs-tirzepatide-comparison) covers one of them.

## Is Tirzepatide a GLP-1 Receptor Agonist?

Yes, and then some. Tirzepatide is a **dual agonist**. It switches on the GLP-1 receptor and the GIP receptor.

GIP is a second gut hormone in the same "incretin" family. Incretins are gut hormones that boost insulin after meals. Hitting both pathways appears to add to the effect.

Semaglutide, by contrast, is a pure GLP-1 receptor agonist. Our guide to the [incretin effect](https://www.telosrx.com/blogs/glp1/incretin-effect-explained) explains why that difference matters.

## How Much Weight Change Did the Trials Show?

Results vary by drug, dose and person. But the landmark trials set expectations.

In the [STEP 1 trial in the New England Journal of Medicine](https://www.nejm.org/doi/full/10.1056/NEJMoa2032183), adults on semaglutide 2.4 mg saw a mean body-weight change of −14.9% at 68 weeks. The placebo group saw −2.4%. Everyone also got lifestyle counseling.

Those are group averages. Some people responded far more, and some far less. **Individual results vary**, and no medication guarantees a specific outcome.

**Wondering if a GLP-1 fits your goals?** [Compare TelosRX GLP-1 options](https://www.telosrx.com/pages/glp-1-options). Any prescription is subject to medical approval by a licensed provider after an asynchronous online review.

## What Side Effects Are Most Common?

Most side effects are digestive. That makes sense for a drug that slows your stomach. The common ones on FDA labels include:

-   Nausea, especially after dose increases
-   Vomiting or diarrhea
-   Constipation
-   Reduced appetite and early fullness
-   Heartburn, burping or bloating

These often ease as your body adjusts. That's why labels start low and step the dose up slowly. Smaller meals and less greasy food also tend to help.

Less common but serious risks on the labels include pancreatitis, gallbladder problems and kidney strain from dehydration. Not sure if a symptom is normal? Our guide on [GLP-1 gastroparesis vs normal side effects](https://www.telosrx.com/blogs/glp1/glp-1-gastroparesis-vs-normal-side-effects) can help you sort it out.

## Who Should Not Take a GLP-1 Receptor Agonist?

Injectable GLP-1 RAs like semaglutide and tirzepatide carry a **boxed warning**. It's about thyroid C-cell tumors seen in rodent studies. Whether this risk applies to people isn't known.

Because of that, labels say not to use them if you have:

-   A personal or family history of medullary thyroid carcinoma (MTC)
-   Multiple endocrine neoplasia syndrome type 2 (MEN 2)
-   A known serious allergy to the drug

Extra caution applies with a history of pancreatitis, during pregnancy, or before surgery. Your provider weighs all of this during review.

## Are Compounded GLP-1 Medications the Same as Brand Names?

No. Compounded versions are prepared by a pharmacy under federal compounding rules. They are **not FDA-approved**, and they don't go through FDA review for safety, effectiveness or quality before use.

The FDA has [publicly raised concerns about unapproved GLP-1 products](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss). That includes fraudulent products and ones sold "for research purposes."

The takeaway is simple. Source matters. A legitimate route involves a licensed provider, a real prescription and a properly regulated pharmacy.

## Do GLP-1 Drugs Do Anything Beyond Weight and Blood Sugar?

Researchers think so. Some benefits are already on FDA labels. For example, Wegovy is approved to reduce the risk of major heart events in certain adults with heart disease and excess weight.

Other areas are still being studied. They include liver fat, kidney health, sleep apnea and even addictive behaviors. Most of these uses remain investigational for now.

## How Long Do People Stay on GLP-1 Receptor Agonists?

For many people, it's long-term. Trials that stopped the medication saw appetite and weight trend back up over time.

That doesn't mean forever for everyone. Some people taper under supervision. Others move to a maintenance dose. Protecting muscle with protein and strength training matters either way.

## Frequently Asked Questions

### What is the difference between GLP-1 and a GLP-1 receptor agonist?

GLP-1 is the natural hormone your gut makes after meals. It breaks down within minutes. A GLP-1 receptor agonist is a medication built to switch on the same receptor but last much longer, often a full week. That longer action is what produces steady effects on appetite and blood sugar.

### Are GLP-1 receptor agonists the same as Ozempic?

Ozempic is one brand of GLP-1 receptor agonist. Its active ingredient is semaglutide, and it's FDA-approved for type 2 diabetes. Other GLP-1 receptor agonists include liraglutide, dulaglutide and exenatide. Tirzepatide is related but acts on both GLP-1 and GIP receptors.

### Is a GLP-1 receptor agonist the same as insulin?

No. Insulin directly lowers blood sugar. A GLP-1 receptor agonist helps your pancreas release more of its own insulin, mostly when blood sugar is high. It also slows digestion and reduces appetite. Some people with diabetes use both, which raises the risk of low blood sugar and needs careful dosing.

### How fast do GLP-1 receptor agonists start working?

Appetite changes often show up within the first few weeks. Weight and blood sugar changes build over months as the dose steps up. In major trials, the largest average changes appeared after a year or more. Starting doses are low on purpose, so early effects may feel mild.

### Can you take a GLP-1 receptor agonist without diabetes?

Yes, for certain brands. Wegovy, Zepbound and Saxenda are FDA-approved for chronic weight management in adults who meet BMI criteria. Ozempic and Mounjaro are approved for type 2 diabetes. A licensed provider decides which option, if any, fits your health history.

### Do GLP-1 receptor agonists cause muscle loss?

Some lean mass loss happens with most weight loss, including on GLP-1 drugs. How much varies by person. Eating enough protein and doing regular strength training are the main ways to help protect muscle. Tracking body composition, not just scale weight, gives a clearer picture of progress.

_TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service._

Start your private evaluation at [TelosRX](https://telosrx.com).

**Tags:** expert Q&A, GLP-1 mechanism, GLP-1 receptor agonist, GLP-1 side effects, semaglutide, tirzepatide

---

> Source: [Telos RX](https://www.telosrx.com/blogs/glp1/glp-1-receptor-agonists-questions-answered)
